| Year |
Citation |
Score |
| 2024 |
Millett M, Heuberger A, Castosa EM, Comite A, Wagner P, Hall D, Gallardo I, Chambers NE, Wagner L, Moehle MS. α Regulates Biochemical Signaling in Neurons Associated with Movement Control and Initiation. Biorxiv : the Preprint Server For Biology. PMID 38617339 DOI: 10.1101/2024.04.03.587766 |
0.603 |
|
| 2024 |
Centner A, Del Priore I, Chambers N, Cohen SR, Terry ML, Coyle M, Glinski J, Stoll AC, Patterson JR, Kemp CJ, Miller KM, Kubik M, Kuhn N, Luk KC, Sortwell CE, et al. Deficits in basal and evoked striatal dopamine release following alpha-synuclein preformed fibril injection: An in vivo microdialysis study. The European Journal of Neuroscience. PMID 38356120 DOI: 10.1111/ejn.16275 |
0.598 |
|
| 2023 |
Chambers NE, Millett M, Moehle MS. The muscarinic M4 acetylcholine receptor exacerbates symptoms of movement disorders. Biochemical Society Transactions. 51: 691-702. PMID 37013974 DOI: 10.1042/BST20220525 |
0.619 |
|
| 2021 |
Chambers NE, Coyle M, Sergio J, Lanza K, Saito C, Topping B, Clark SD, Bishop C. Effects of Pedunculopontine Nucleus Cholinergic Lesion on Gait and Dyskinesia in Hemiparkinsonian Rats. The European Journal of Neuroscience. PMID 33426708 DOI: 10.1111/ejn.15106 |
0.605 |
|
| 2019 |
Chambers NE, Lanza K, Bishop C. Pedunculopontine Nucleus Degeneration Contributes to Both Motor and Non-Motor Symptoms of Parkinson's Disease. Frontiers in Pharmacology. 10: 1494. PMID 32009944 DOI: 10.3389/Fphar.2019.01494 |
0.589 |
|
| 2019 |
Lanza K, Chemakin K, Lefkowitz S, Saito C, Chambers N, Bishop C. Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat. Psychopharmacology. PMID 31435690 DOI: 10.1007/S00213-019-05353-6 |
0.592 |
|
| 2019 |
Chambers NE, Meadows SM, Taylor A, Sheena E, Lanza K, Conti MM, Bishop C. Effects of Muscarinic Acetylcholine m1 and m4 Receptor Blockade on Dyskinesia in the Hemi-Parkinsonian Rat. Neuroscience. PMID 31029732 DOI: 10.1016/J.Neuroscience.2019.04.008 |
0.629 |
|
| 2019 |
Sellnow RC, Newman JH, Chambers N, West AR, Steece-Collier K, Sandoval IM, Benskey MJ, Bishop C, Manfredsson FP. Regulation of dopamine neurotransmission from serotonergic neurons by ectopic expression of the dopamine D2 autoreceptor blocks levodopa-induced dyskinesia. Acta Neuropathologica Communications. 7: 8. PMID 30646956 DOI: 10.1186/S40478-018-0653-7 |
0.63 |
|
| 2018 |
Meadows SM, Conti MM, Gross L, Chambers NE, Avnor Y, Ostock CY, Lanza K, Bishop C. Diverse serotonin actions of vilazodone reduce l-3,4-dihidroxyphenylalanine-induced dyskinesia in hemi-parkinsonian rats. Movement Disorders : Official Journal of the Movement Disorder Society. 33: 1740-1749. PMID 30485908 DOI: 10.1002/Mds.100 |
0.54 |
|
| 2018 |
Lanza K, Meadows SM, Chambers NE, Nuss E, Deak MM, Ferré S, Bishop C. Behavioral and cellular dopamine D and D receptor-mediated synergy: Implications for L-DOPA-induced dyskinesia. Neuropharmacology. PMID 29936243 DOI: 10.1016/J.Neuropharm.2018.06.024 |
0.607 |
|
| 2018 |
Conti MM, Chambers N, Bishop C. A new outlook on cholinergic interneurons in Parkinson's disease and L-DOPA-induced dyskinesia. Neuroscience and Biobehavioral Reviews. PMID 29782883 DOI: 10.1016/J.Neubiorev.2018.05.021 |
0.641 |
|
| 2017 |
Meadows SM, Chambers NE, Conti MM, Bossert SC, Tasber C, Sheena E, Varney M, Newman-Tancredi A, Bishop C. Characterizing the differential roles of striatal 5-HT1A auto- and hetero-receptors in the reduction of l-DOPA-induced dyskinesia. Experimental Neurology. 292: 168-178. PMID 28342749 DOI: 10.1016/J.Expneurol.2017.03.013 |
0.543 |
|
| Show low-probability matches. |